INTRODUCTION: Electronic cigarettes (ECs) are marketed as nicotine delivery devices. Two studies with EC-naïve participants suggest that ECs deliver little or no nicotine. In those studies, standard-sized ECs were used, though experienced EC users often use larger devices that house higher voltage and/or longer lasting batteries. Whether user experience and device characteristics influence EC nicotine delivery is uncertain. The purpose of the present study was to examine the effects of ECs in experienced users who were using their preferred devices. METHODS: Eight EC users (3 women) who had been using ECs for at least 3 months, completed one 5-hr session using devices they provided and the flavor/strength nicotine cartridges they selected. Sessions consisted of 4 phases: baseline, 10 puffs (30-s interpuff interval) from the device, 1-hr ad lib puffing period, and a 2-hr rest period (no puffing). Outcome measures in each phase included plasma nicotine concentration, heart rate, and subjective ratings of nicotine/product effects and abstinence symptoms. RESULTS: Relative to baseline, plasma nicotine and heart rate increased significantly within 5 min of the first puff and remained elevated throughout the ad lib puffing period. Increases in ratings of direct effects of nicotine and product were observed as well as decreases in abstinence symptoms. CONCLUSIONS: User experience and/or device characteristics likely influence EC nicotine delivery and other effects. Systematic manipulation of these and other variables could elucidate conditions that produce intended effects.
INTRODUCTION: Electronic cigarettes (ECs) are marketed as nicotine delivery devices. Two studies with EC-naïve participants suggest that ECs deliver little or no nicotine. In those studies, standard-sized ECs were used, though experienced EC users often use larger devices that house higher voltage and/or longer lasting batteries. Whether user experience and device characteristics influence EC nicotine delivery is uncertain. The purpose of the present study was to examine the effects of ECs in experienced users who were using their preferred devices. METHODS: Eight EC users (3 women) who had been using ECs for at least 3 months, completed one 5-hr session using devices they provided and the flavor/strength nicotine cartridges they selected. Sessions consisted of 4 phases: baseline, 10 puffs (30-s interpuff interval) from the device, 1-hr ad lib puffing period, and a 2-hr rest period (no puffing). Outcome measures in each phase included plasma nicotine concentration, heart rate, and subjective ratings of nicotine/product effects and abstinence symptoms. RESULTS: Relative to baseline, plasma nicotine and heart rate increased significantly within 5 min of the first puff and remained elevated throughout the ad lib puffing period. Increases in ratings of direct effects of nicotine and product were observed as well as decreases in abstinence symptoms. CONCLUSIONS: User experience and/or device characteristics likely influence EC nicotine delivery and other effects. Systematic manipulation of these and other variables could elucidate conditions that produce intended effects.
Authors: Bethea A Kleykamp; Janine M Jennings; Cynthia Sams; Michael F Weaver; Thomas Eissenberg Journal: Exp Clin Psychopharmacol Date: 2008-04 Impact factor: 3.157
Authors: Maciej L Goniewicz; Ribhav Gupta; Yong Hee Lee; Skyler Reinhardt; Sungroul Kim; Bokyeong Kim; Leon Kosmider; Andrzej Sobczak Journal: Int J Drug Policy Date: 2015-02-07
Authors: Jan Czogala; Maciej L Goniewicz; Bartlomiej Fidelus; Wioleta Zielinska-Danch; Mark J Travers; Andrzej Sobczak Journal: Nicotine Tob Res Date: 2013-12-11 Impact factor: 4.244
Authors: Deepa R Camenga; Dana A Cavallo; Grace Kong; Meghan E Morean; Christian M Connell; Patricia Simon; Sandra M Bulmer; Suchitra Krishnan-Sarin Journal: Nicotine Tob Res Date: 2015-02-02 Impact factor: 4.244
Authors: Paul T Harrell; Syeda Mahrukh Hussnain Naqvi; Andrew D Plunk; Ming Ji; Silvia S Martins Journal: Am J Drug Alcohol Abuse Date: 2016-09-26 Impact factor: 3.829
Authors: Andrew J Barnes; Rose S Bono; Alyssa K Rudy; Cosima Hoetger; Nicole E Nicksic; Caroline O Cobb Journal: Addiction Date: 2020-05-14 Impact factor: 6.526
Authors: Adam M Leventhal; David R Strong; Matthew G Kirkpatrick; Jennifer B Unger; Steve Sussman; Nathaniel R Riggs; Matthew D Stone; Rubin Khoddam; Jonathan M Samet; Janet Audrain-McGovern Journal: JAMA Date: 2015-08-18 Impact factor: 56.272